Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by schocoron Jan 29, 2021 3:14pm
125 Views
Post# 32422502

RE:RE:RE:GUD hunting for safe bargains?

RE:RE:RE:GUD hunting for safe bargains? "Most times" is not the kind of analysis that I usually look to for advice when investing. Can you name me one other Pharma company who has lost the C Suite and chairman and had their stock price improve? Don't waste your time looking...I already know the answer (suspect you do too). I have one posting name on stockhouse for 10+ years I think and have never changed my username. But now that I see you are one of THOSE stock house conspiracy posters - I take your comments as even less credible than I did before. Keep posting Bendtict, I wont be bothering you moving forward now that I know what your are all about and suggest others can do the same. You just aren't worth the time.
<< Previous
Bullboard Posts
Next >>